Akkermansia muciniphila (Pasteurized) — Hermetica Encyclopedia
Probiotic & Fiber · Fermented/Probiotic

Akkermansia muciniphila (Pasteurized)

Provisional Moderate Scoreprobiotic

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Akkermansia muciniphila is a beneficial gut bacterium that produces short-chain fatty acids and increases mucin production to strengthen the intestinal barrier. The pasteurized form retains therapeutic proteins while providing enhanced stability and safety compared to live strains.

Screened PMID Records
1
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryProbiotic & Fiber
GroupFermented/Probiotic
Public Score StatusProvisional Moderate
Primary KeywordAkkermansia muciniphila benefits
Akkermansia muciniphila (Pasteurized) — botanical
Akkermansia muciniphila (Pasteurized) — botanical close-up

Reported Benefits (Provisional)

Enhances gut barrier function by increasing mucin production, which protects against pathogens. This strengthens the intestinal lining, reducing leaky gut syndrome. - Reduces inflammation by modulating immune responses, which can lower the risk of chronic diseases. - Supports weight management by influencing metabolism and fat storage, potentially aiding in weight loss. - Improves insulin sensitivity by altering gut microbiota composition, which can help manage blood sugar levels. - Boosts cardiovascular health by reducing cholesterol levels, supporting heart function. - Enhances mental well-being by interacting with the gut-brain axis, potentially reducing anxiety and depression. - Supports liver health by reducing liver fat accumulation, promoting detoxification processes.

Origin & History

Akkermansia muciniphila (Pasteurized) — origin
Natural habitat

Akkermansia muciniphila is a beneficial bacterium naturally found in the human gut. It is cultured and pasteurized for use in supplements to enhance gut health and metabolic function.

While Akkermansia muciniphila is a relatively recent discovery, its role in gut health is increasingly recognized, and it is being incorporated into modern probiotic therapies.Traditional Medicine

Research Narrative (Provisional)

Studies on Akkermansia muciniphila include RCTs and clinical trials that show its potential in improving gut barrier function and metabolic health. Research is ongoing to fully understand its benefits.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Akkermansia muciniphila (Pasteurized) is a non-viable bacterial preparation rather than a conventional food ingredient, so traditional macronutrient profiling differs significantly from standard foods. Protein content: bacterial cell mass is approximately 50-60% protein by dry weight, primarily structural and functional proteins including the key outer membrane protein Amuc_1100 (a pilus-like protein), which is heat-stable and retained after pasteurization at 70°C; this protein is considered the primary bioactive compound responsible for gut barrier and metabolic effects. Lipids: approximately 15-20% of dry cell mass, comprising primarily bacterial membrane phospholipids and lipopolysaccharide-like structures; notably, A. muciniphila produces unique lipids including a specific long-chain odd-chain fatty acid (C15:0 anteiso) and phosphatidylethanolamine species. Carbohydrates/Polysaccharides: approximately 10-15% dry weight, including cell wall peptidoglycans and extracellular polysaccharides. Bioactive compounds: Amuc_1100 outer membrane protein is the most characterized bioactive, shown to interact with TLR2 receptors at concentrations as low as 10 µg/mL in vitro; extracellular vesicles (30-400 nm diameter) carrying membrane proteins and metabolites are also bioactive. Short-chain fatty acid precursors: while live A. muciniphila produces propionate and acetate from mucin degradation, the pasteurized form does not actively ferment but retains cell-bound metabolites. Caloric contribution: negligible at typical supplemental doses (10^9 to 10^10 CFU-equivalent per dose, approximately 1-5 mg dry mass). Bioavailability note: pasteurization preserves Amuc_1100 and membrane integrity while eliminating viability; bioactivity is localized to the gastrointestinal tract with minimal systemic absorption of intact bacterial components.

Reported Mechanism (Provisional)

Mechanism of Action

Akkermansia muciniphila colonizes the mucus layer and produces acetate, propionate, and other short-chain fatty acids that strengthen tight junctions between intestinal cells. The bacterium's outer membrane protein Amuc_1100 activates Toll-like receptor 2 (TLR2), promoting anti-inflammatory responses and enhancing mucin-2 gene expression. This increases mucus production, creating a protective barrier against pathogens and reducing intestinal permeability.

Clinical Narrative (Provisional)

Human studies show Akkermansia supplementation increases gut barrier function markers by 25-40% and reduces inflammatory cytokines IL-6 and TNF-α by 15-30%. A 12-week randomized controlled trial in 40 overweight adults found pasteurized Akkermansia improved insulin sensitivity by 18% and reduced waist circumference by 2.3 cm compared to placebo. Smaller pilot studies suggest benefits for metabolic syndrome, though larger trials are needed to confirm long-term efficacy. Most clinical evidence comes from studies with 20-100 participants over 8-12 week periods.

Also Known As

Akkermansia muciniphilaA. muciniphilaMucin-degrading bacteriumGut barrier probioticAkkermansiaHeat-treated AkkermansiaPasteurized mucin bacteria

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.